- Home
- OVID vs VTVT Comparison
OVID vs VTVT Comparison
Compare OVID & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- VTVT
- Stock Information
- Founded
- OVID 2014
- VTVT 2015
- Country
- OVID United States
- VTVT United States
- Employees
- OVID N/A
- VTVT N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- OVID Health Care
- VTVT Health Care
- Exchange
- OVID Nasdaq
- VTVT Nasdaq
- Market Cap
- OVID 47.1M
- VTVT 38.8M
- IPO Year
- OVID 2017
- VTVT 2015
- Fundamental
- Price
- OVID $0.62
- VTVT $20.20
- Analyst Decision
- OVID Strong Buy
- VTVT Strong Buy
- Analyst Count
- OVID 6
- VTVT 1
- Target Price
- OVID $4.03
- VTVT $35.00
- AVG Volume (30 Days)
- OVID 467.5K
- VTVT 8.9K
- Earning Date
- OVID 03-07-2025
- VTVT 03-12-2025
- Dividend Yield
- OVID N/A
- VTVT N/A
- EPS Growth
- OVID N/A
- VTVT N/A
- EPS
- OVID N/A
- VTVT N/A
- Revenue
- OVID $631,695.00
- VTVT $1,000,000.00
- Revenue This Year
- OVID $71.38
- VTVT N/A
- Revenue Next Year
- OVID N/A
- VTVT N/A
- P/E Ratio
- OVID N/A
- VTVT N/A
- Revenue Growth
- OVID 113.21
- VTVT 11011.11
- 52 Week Low
- OVID $0.56
- VTVT $8.10
- 52 Week High
- OVID $3.79
- VTVT $30.99
- Technical
- Relative Strength Index (RSI)
- OVID 38.62
- VTVT 63.15
- Support Level
- OVID $0.56
- VTVT $19.02
- Resistance Level
- OVID $0.67
- VTVT $20.89
- Average True Range (ATR)
- OVID 0.06
- VTVT 1.15
- MACD
- OVID 0.00
- VTVT 0.30
- Stochastic Oscillator
- OVID 35.94
- VTVT 68.18
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.